Photocure ASA: Notification of primary insider transaction

Published: 30 August 2023

Oslo, Norway, 30 August 2023: Board member Dylan Hallerberg has on 29 August 2023 acquired 150,000 shares at an average price of NOK 43.33.

Primary insider notification pursuant to the market abuse regulation article 19 is attached.

For further information, please contact:

CFO Erik Dahl
Tel: +47 450 55 000

About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at, or

All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.

This information is subject to the disclosure requirements pursuant to the market abuse regulation article 19 and 5-12 of the Norwegian Securities Trading Act.

News and events